US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.194
  • -0.007-3.67%
Close Nov 1 16:00 ET
  • 0.194
  • 0.0000.00%
Post 19:58 ET
7.66MMarket Cap-167P/E (TTM)

Viracta Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Oct 31, 2024

Based on 2 analysts giving stock ratings to Viracta Therapeutics in the past 3 months

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

The average Viracta Therapeutics stock price target is 3.50 with a max estimate of 4.00 and a min estimate of 3.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Oct 31, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

Updated: Oct 31, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data